Health Net
Herceptin Hylecta (trastuzumab-hyaluronidase-oysk)
Drugs for Cancer : Drugs for Cancer
  • Prior Authorization: Breast Cancer: HR+ (HER2+):
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Age Requirement: >= 18
    Duration: 6 Month(s)
    Reauthorization Required: Yes

  • Breast Cancer: HR+ (HER2+):
    Age Requirement: >= 18
    Duration: 6 Month(s)
    Specialist Required: Yes
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Specialist Type(s): Oncologist
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)

  • Step Therapy: Breast Cancer: HR+ (HER2+):
    ST Multiple Brands